While all of them were independently associated with CVD risk, we observed for the first time that combining NT-proBNP and HbA1C associates strongly with breast cancer risk, GDF-15 and NT-proBNP with prostate cancer risk, and GDF-15 and HbA1C with lung cancer risk. Here, GDF15 is linked to HbA1c measurement.